An unmet need in hypoparathyroidism is combating the associated rise in serum phosphate levels, which are largely unaffected by conventional therapies.(12, 50) Active vitamin D is unable to match the phosphaturic action of PTH and can even worsen hyperphosphatemia, by promoting intestinal phosphate absorption. This evidence concerns the gene PTH and hyperphosphatemia.